rs746016355
Variant summary
Our verdict is Pathogenic. The variant received 10 ACMG points: 10P and 0B. PVS1PM2
The NM_001365276.2(TNXB):c.4996C>T(p.Arg1666*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000348 in 1,435,200 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001365276.2 stop_gained
Scores
Clinical Significance
Conservation
Publications
- Ehlers-Danlos syndromeInheritance: AR Classification: DEFINITIVE Submitted by: G2P
- Ehlers-Danlos syndrome due to tenascin-X deficiencyInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Illumina, PanelApp Australia, Orphanet
- familial vesicoureteral refluxInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- vesicoureteral reflux 8Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 10 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| TNXB | NM_001365276.2 | c.4996C>T | p.Arg1666* | stop_gained | Exon 14 of 44 | ENST00000644971.2 | NP_001352205.1 | |
| TNXB | NM_001428335.1 | c.5737C>T | p.Arg1913* | stop_gained | Exon 15 of 45 | NP_001415264.1 | ||
| TNXB | NM_019105.8 | c.4996C>T | p.Arg1666* | stop_gained | Exon 14 of 44 | NP_061978.6 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| TNXB | ENST00000644971.2 | c.4996C>T | p.Arg1666* | stop_gained | Exon 14 of 44 | NM_001365276.2 | ENSP00000496448.1 | |||
| TNXB | ENST00000647633.1 | c.5737C>T | p.Arg1913* | stop_gained | Exon 15 of 45 | ENSP00000497649.1 | ||||
| TNXB | ENST00000375244.7 | c.4996C>T | p.Arg1666* | stop_gained | Exon 14 of 44 | 5 | ENSP00000364393.3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.00000846 AC: 2AN: 236470 AF XY: 0.0000154 show subpopulations
GnomAD4 exome AF: 0.00000348 AC: 5AN: 1435200Hom.: 0 Cov.: 31 AF XY: 0.00000422 AC XY: 3AN XY: 710340 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Ehlers-Danlos syndrome due to tenascin-X deficiency Uncertain:1
The p.Arg1666X variant in TNXB has not been previously reported in the literature but has been identified in 1/13218 South Asian chromosomes by the Exome Aggregation Consortium (ExAC) (http://exac.broadinstitute.org). This nonsense variant leads to a premature termination codon at position 1666, which is predicted to lead to a truncated or absent protein. Complete loss of TNXB function has been described in a few families with Ehlers-Danlos-like syndrome (Schalkwijk 2001, Merke 2013, Penisson-Besnier 2013) and a TNXB mouse knockout model indicates that complete loss of TNXB function results in abnormal collagen deposition (Mao 2002). In summary, while there is some suspicion for a pathogenic role of loss-of-function TNXB variants in Ehlers-Danlos-like syndrome, the clinical significance of the p.Arg1666X variant is uncertain. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at